Wêrom Medysk Ûndersyk Meastentiids Troch de Yndustry Finansierd Wurdt
June 9, 2026 · Frisian News
Pharmaceutical companies finance more than half of medical research in wealthy countries, usually funding studies of their own drugs. The financial overlap creates measurable bias: industry-funded research shows favorable results three times more often than independent studies.
FryskFarmabedriuwen finansierje mear as de helte fan al it medysk ûndersyk yn de rykste lannen fan 'e wrâld. In arts ûndersiket in diabetes-genêsmiddel. In ûndersiker testet in nij pynstiller. In team fergeliket kankerbehannelingen. Meastentiids is de pillenmakker dy't it ûndersyk betellet itselde bedriuw dat de pil ferkeapet. Dit is gjin bug. Dit is hoe't it systeem wurket.
Studies toane oan dat dit foaroardiel echt en mjitber is. Ûndersyk finansierd troch in farmabedriuw toant trijekear faker positive resultaten foar de behanneling fan dat bedriuw oan as ûnôfhinklik ûndersyk. It patroan jildt foar alle sykten. Psychiatryske genêsmiddels, hertmedisinen, kankerbehannelingen. It bedriuw finansiert de stúdzje. De stúdzje fynt dat it genêsmiddel wurket. Dan komme de resultaten yn medyske hânboeken en op reseptenblokken fan artsen. Nimmen neamt dit korrupsje. Tydskriften publisearje it. Regeljouwers akseptearje it. Universiteiten binne grutsk op de opbringsten fan it ûndersyk.
Dit systeem bepalet wat der earst ûndersiket wurdt. In pillenmakker finansiert ûndersyk nei djoere nije genêsmiddels. Nimmen finansiert ûndersyk nei oft it âlde goedkeape genêsmiddel better wurket. In faksinmakker finansiert ûndersiken fan syn eigen faksinen. Ûnôfhinklike fergelikingsstúdzjes fine net plak, of as se barre, wrakselje se om publisearre te wurden. It bedriuw profitearret. De arts tinkt dat er de wittenskip folget. De pasjint slikt it genêsmiddel. Mar de wittenskip sels is stil op winst rjochte, net op wierheid.
As dit ter sprake komt, is it ekskús altyd itselde. Bedriuwsfinansiering is needsaaklik. Regearingen en goede doelen hawwe net genôch jild. Universiteiten hawwe de opbringsten nedich. Ûndersikers hawwe beurzen nedich. Allegear wier. Mar dat lit it konflikt net ferdwine. It betsjut dat wy foaroardiel akseptearje as de priis fan foarútgong. Wy hawwe besletten dat bedriuwsfinansiering wichtiger is as ûnôfhinklikheid. Wy hawwe besletten dat de skyn fan konflikt akseptabel is salang't minsken it mar iepenbier meitsje. Iepenbier meitsjen feroaret it foaroardiel net. It neamt it allinne.
De eigentlike fraach is net oft artsen en ûndersikers korrupt binne. De measte binne earlik. De fraach is oft in systeem wêryn winst en ûndersyk oan inoar fêst sitte de genêsmiddels fuortbringt dy't wy nedich hawwe. De gegevens suggerearje fan net. Mar it systeem hat gjin reden om dit goed te ûndersykjen.
Pharmaceutical companies fund more than half of all medical research in the world's richest countries. A doctor studies a diabetes drug. A researcher tests a new painkiller. A team compares cancer treatments. Usually, the pill maker that funds the study is the same company that sells the pill. This is not a bug. This is how the system works.
Studies show the bias is real and measurable. Research funded by a drug company is three times more likely to show positive results for that company's treatment than independent research shows. The pattern holds across diseases. Psychiatric drugs, heart medications, cancer therapies. The company funds the trial. The trial finds the drug works. Then the results go into medical textbooks and onto doctors' prescription pads. No one calls this corruption. Journals publish it. Regulators accept it. Universities pride themselves on the research revenue.
This system shapes what gets studied in the first place. A pill company funds research on expensive new drugs. No one funds research on whether the old cheap drug still works better. A vaccine maker funds studies of its own shots. Independent comparison studies do not get made, or if they do, they struggle to get published. The company profits. The doctor thinks they are following the science. The patient takes the pill. But the science itself has been quietly pointed toward profit, not truth.
When this gets called out, the excuse is always the same. Industry funding is necessary. Governments and charities do not have the money. Universities need the revenue. Researchers need the grants. All true. But that does not make the conflict disappear. It just means we accept bias as the price of progress. We have decided that industry funding matters more than independence. We have decided that the appearance of conflict is acceptable as long as people disclose it. Disclosure does not fix bias. It just names it.
The real question is not whether doctors and researchers are corrupt. Most are honest. The question is whether a system where profit and research are joined at the hip produces the drugs we actually need. The data suggests it does not. But the system has no reason to study that question too closely.
Published June 9, 2026 · Frisian News · Ljouwert, Fryslân